As of 2025-09-09, the Relative Valuation of Yabao Pharmaceutical Group Co Ltd (600351.SS) is 5.37 CNY. This relative valuation is based on P/E multiples. With the latest stock price at 7.05 CNY, the upside of Yabao Pharmaceutical Group Co Ltd based on Relative Valuation is -23.9%.
The range of the Relative Valuation is 4.01 - 7.09 CNY.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 20.9x | 19.3x |
| Forward P/E multiples | 14.5x - 16.5x | 15.1x |
| Fair Price | 4.01 - 7.09 | 5.37 |
| Upside | -43.1% - 0.6% | -23.9% |
| Date | P/E |
| 2025-09-08 | 20.76 |
| 2025-09-05 | 20.47 |
| 2025-09-04 | 20.47 |
| 2025-09-03 | 20.41 |
| 2025-09-02 | 20.67 |
| 2025-09-01 | 21.03 |
| 2025-08-29 | 20.59 |
| 2025-08-28 | 20.70 |
| 2025-08-27 | 20.76 |
| 2025-08-26 | 21.41 |
| 2025-08-25 | 21.53 |
| 2025-08-22 | 21.53 |
| 2025-08-21 | 21.79 |
| 2025-08-20 | 21.67 |
| 2025-08-19 | 21.91 |
| 2025-08-18 | 21.76 |
| 2025-08-15 | 21.91 |
| 2025-08-14 | 21.70 |
| 2025-08-13 | 21.97 |
| 2025-08-12 | 21.88 |
| 2025-08-11 | 22.53 |
| 2025-08-08 | 22.56 |
| 2025-08-07 | 22.06 |
| 2025-08-06 | 22.82 |
| 2025-08-05 | 23.59 |
| 2025-08-04 | 23.44 |
| 2025-08-01 | 23.41 |
| 2025-07-31 | 22.09 |
| 2025-07-30 | 21.17 |
| 2025-07-29 | 21.09 |
| 2025-07-28 | 20.61 |
| 2025-07-25 | 21.23 |
| 2025-07-24 | 22.41 |
| 2025-07-23 | 20.91 |
| 2025-07-22 | 19.73 |
| 2025-07-21 | 19.82 |
| 2025-07-18 | 19.02 |
| 2025-07-17 | 19.00 |
| 2025-07-16 | 18.82 |
| 2025-07-15 | 18.44 |
| 2025-07-14 | 18.67 |
| 2025-07-11 | 18.55 |
| 2025-07-10 | 18.58 |
| 2025-07-09 | 18.41 |
| 2025-07-08 | 18.49 |
| 2025-07-07 | 18.49 |
| 2025-07-04 | 18.44 |
| 2025-07-03 | 18.52 |
| 2025-07-02 | 18.17 |
| 2025-07-01 | 18.11 |